Shares in Biogen (NSDQ:BIIB) rose today after the biopharmaceutical company met expectations on Wall Street with its second quarter results.
The Cambridge, Mass.-based company posted profits of $863 million, or $4.07 per share, on sales of $3.1 billion for the 3 months ended June 30, for bottom-line loss of -18% on sales growth of 6% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Biogen lifts outlook after strong Q2 appeared first on MassDevice.
from MassDevice http://ift.tt/2vGIy8M
Cap comentari:
Publica un comentari a l'entrada